Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol
Completed
- Conditions
- Cancer Pain
- Registration Number
- NCT01230515
- Lead Sponsor
- Vanderbilt-Ingram Cancer Center
- Brief Summary
The purpose of this study is to modify the opioid titration order sheet to meet the needs of the outpatient hospice population and to conduct a pilot trial to assess feasibility, utility, and derive preliminary efficacy data.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
-
Patient eligibility includes:
- Alive Hospice outpatient
- Diagnosis of carcinoma
- Pain requiring fixed dose opioids
- Age > 21 years
- Not pregnant or lactating
- Willing and able to sign informed consent
- Able to speak/comprehend English
Caregiver eligibility will include:
- Caregiver for an Alive Hospice patient
- Willing and able to sign informed consent
- Able to speak/comprehend English
Hospice Staff eligibility will include:
- Currently on staff at Alive Hospice
- Willing and able to sign informed consent
- Able to read/speak English.
Referring Physician eligibility will include:
- Having recently referred patients to Alive Hospice
- Willing and able to sign informed consent and able to read/speak English.
Exclusion Criteria
- patients < 21 years of age
- pregnant or lactating
- patients, caregiver and or Hospice staff that does not speak/comprehend English
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adequate pain control Until death.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Vanderbilt-Ingam Cancer Center
🇺🇸Nashville, Tennessee, United States
Vanderbilt-Ingam Cancer Center🇺🇸Nashville, Tennessee, United States